jeremiah@devisedesigns.com, Author at Corcept Therapeutics - Page 9 of 16

About jeremiah@devisedesigns.com

This author has not written his bio yet.
But we are proud to say that jeremiah@devisedesigns.com contributed 156 entries already.

Entries by jeremiah@devisedesigns.com

Hypercortisolism (Cushing syndrome)

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

Pivonello et al • 2021 • Front. Endocrinol., 14 July 2021

July 15, 2021

A Double-Blind, Randomized, Placebo-Controlled Phase 3 Study to Assess the Ef cacy and Safety of Relacorilant, a Selective Glucocorticoid Receptor Modulator, in Patients With Hypercortisolism Due to Cortisol-Secreting Adrenal Adenoma(s)/Hyperplasia

• •

September 4, 2020

IChiodini ECE2020-1

• •

September 4, 2020

AGreenstein ECE2020-2

• •

September 4, 2020

Relacorilant With Nab-paclitaxel: Safety and Activity in Patients With Pancreatic Ductal Adenocarcinoma and Ovarian Cancer

Munster et al. • 2019 •

August 7, 2020

Hypercortisolism (Cushing syndrome)

Efficacy and Safety of the Selective Glucocorticoid Receptor Modulator, Relacorilant (up to 400 mg/day), in Patients With Endogenous Hypercortisolism

Pivonello et al. • 2019 • American Association of Clinical Endocrinologists (AACE) 28th Annual Scientific & Clinical Congress

August 3, 2020

ASCO2020-1

• •

May 29, 2020

Selective Glucocorticoid Receptor Modulation Prevents and Reverses Nonalcoholic Fatty Liver Disease in Male Mice

Koorneef et al. • 2018 • Endocrinology. 2018, 159(12):3925–3936

December 3, 2019

Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine-induced weight gain.

Belanoff et al. • 2010 • Diabetes Obes Metab. 2010;12(6):545-7.

December 2, 2019

Hypercortisolism (Cushing syndrome)

Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess: A Systematic Review and Meta-analysis

Elhassan et al • 2019 • Ann Intern Med.

November 10, 2019

© 2024 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Your Privacy Choices